Transcriptional activation of HIV by Mycobacterium tuberculosis in human monocytes

Clinical and Experimental Immunology

Volumn 117, Issue 2, 1999, Pages 324-330

  Toossi, Zahra ^a,b   Xia, L ^a   Wu, M ^a   Salvekar, A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Affairs Medical Center   (United States)

Author keywords

HIV; Monocytes; Purified protein derivative; Transcription; Tuberculosis

Indexed keywords

ANTIGEN P24; CYTOKINE; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBERCULOSIS; VIRUS ACTIVATION; VIRUS TRANSCRIPTION;

CELLS, CULTURED; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; TRANS-ACTIVATION (GENETICS); TUBERCULIN; TUMOR NECROSIS FACTOR-ALPHA; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 0032817723     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00952.x     Document Type: Article

References (38)

1. 1 Barnes PF, Bloch AB, Davidson PT, Snider DEJ. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324:1644-50.
2. 2 World Health Organization Report on the TB epidemic. WHO/TB 1994; 94:177.
3. 3 Goletti D, Weissman D, Jackson RW et al. Effect of Mycobacterium tuberculosis on HIV replication. J Immunol 1996; 157:1271-8.
4. 4 Whalen C, Horsburgh CR, Hom D et al. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151:129-35.
5. 5 Lederman MM, Georges DL, Kusner DJ et al. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J Acquir Immune Defic Syndr 1994; 7:727-33.
6. 6 Zhang Y, Nakata K, Weiden M, Rom WN. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J Clin Invest 1995; 95:2324-31.
7. 7 Toossi Z, Nicolacakis K, Xia L, Rich EA. Activation of human immunodeficiency virus-1 in alveolar macrophages from patients with acquired immunodeficiency syndrome by Mycobacterium tuberculosis. J Acquir Immune Defic Syndr 1997; 15:325-31.
8. 8 Nakata K, Rom WN, Honda Y et al. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med 1997; 155:996-1003.
9. 9 Toossi Z, Sierra Madero JG, Blinkhorn RA et al. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med 1993; 177:1511-6.
10. 10 Valone SE, Rich EA, Wallis RS, Ellner JJ. Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun 1988; 56:3313-5.
11. 11 Wallis RS, Fujiwara H, Ellner JJ. Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J Immunol 1986; 136:193-6.
12. 12 Vicenzi E, Biswas P, Mengozzi M, Poli G. Role of pro-inflammatory cytokines and b-chemokines in controlling HIV replication. J Leuk Biol 1977; 62:34-40.
13. 13 Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384:529-34.
14. 14 O'Brien WA, Grovit-Ferbas K, Namazi A et al. Human immunodeficiency virus-type I replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995; 86:1082-9.
15. 15 Stanely SK, Ostrwski MA, Justement JS et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996; 334:1222-30.
16. 16 Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21 (Suppl. 97):9-29.
17. 17 Kaplow KS. Simplified myeloperoxidase staining using benzidine hydrochloride. Blood 1965; 26:215-9.
18. 18 Rich EA, Chen IS, Zack JA et al. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 1992; 89:176-83.
19. 19 Wallis RS, Amir-tahmasseb M, Ellner JJ. Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte Western blot. Proc Acad Natl Sci USA 1990; 87:3348-52.
20. 20 Zack JA, Arrigo SJ, Weitsman SR et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61:213-22.
21. 21 Rice AP, Mathews MB. Trans-activation of the human immunodeficiency virus long terminal repeat sequences expressed in an adenovirus vector by the adenovirus E1A I3S protein. Proc Natl Acad Sci USA 1988; 85:4200-4.
22. 22 Graham FL, Van Der Eb EJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52:465-7.
23. 23 Hadda H. Lopez M, Martinache C et al. Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Commun 1993; 3:1174-83.
24. 24 Gowda SD, Stein BS, Mohagheghpour N et al. Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol 1989; 142:773-80.
25. 25 Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990; 9:1551-60.
26. 26 Schuitemaker H, Koostran NA, Fouchier RAM et al. Productive HIV-1 infection of macrophages restricted to cell fraction with proliferative capacity. EMBO J 1994; 13:5929-36.
27. 27 Alcami J, Lera TL, Folgueira L et al. Absolute dependence on κB responsive elements for initiation and tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 1995; 14:1552-61.
28. 28 Toossi ZBD, Hamilton BDLE, Averill LE et al. Regulation of nuclear factor kappa B (NF-κB) and its inhibitor, IkBα/MAD3 in monocytes during active tuberculosis and by purified protein derivative of M. tuberculosis. J Immunol 1995; 59:4109-16.
29. 29 Rice AP, Mathews MB. Transcriptional but not translational regulation of HIV-1 by tat gene product. Nature 1988; 332:551-3.
30. 30 Rosen CA, Sodroski JG, Haseltine WA. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 1991; 41:813-23.
31. 31 Dal Monte P, Landini MP, Sinclair J et al. TAR and Spl-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus 1E1/1E2. AIDS 1997; 11:297-303.
32. 32 Brake DA, Debouk C, Biescker G. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat. J Cell Biol 1990; 111:1275-81.
33. 33 Bernstein MS, Tong Starksen TE, Locksley RM. Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression. J Clin Invest 1991; 88:540-5.
34. 34 Pomerantz RJ, Feinberg MB, Trono D, Baltimore D. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J Exp Med 1990; 172:253-61.
35. 35 Lazdin JK, Klimkait K, Woods-Cook K et al. In vitro effects of transforming growth factor-β on progression of HIV-1 infection in primary human mononuclear phagocytes. J Immunol 1991; 147:1201-7.
36. 36 Herbein G, Montaner LJ, Gordon S. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor. J Virol 1996; 70:7388-97.
37. 37 Tao-Wook C, Carruth L, Finzi D et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387:183-7.
38. 38 Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science 1997; 276:1857-60.